These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 25406853)

  • 1. Selective inhibitors of protein methyltransferases.
    Kaniskan HÜ; Konze KD; Jin J
    J Med Chem; 2015 Feb; 58(4):1596-629. PubMed ID: 25406853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in developing selective inhibitors of protein methyltransferases.
    Kaniskan HÜ; Jin J
    Curr Opin Chem Biol; 2017 Aug; 39():100-108. PubMed ID: 28662389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical probes of histone lysine methyltransferases.
    Kaniskan HÜ; Jin J
    ACS Chem Biol; 2015 Jan; 10(1):40-50. PubMed ID: 25423077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of Protein Methyltransferases and Demethylases.
    Kaniskan HÜ; Martini ML; Jin J
    Chem Rev; 2018 Feb; 118(3):989-1068. PubMed ID: 28338320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor development.
    Rogawski DS; Grembecka J; Cierpicki T
    Future Med Chem; 2016 Sep; 8(13):1589-607. PubMed ID: 27548565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of protein methyltransferases as chemical tools.
    Luo M
    Epigenomics; 2015; 7(8):1327-38. PubMed ID: 26646500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor.
    Ferreira de Freitas R; Eram MS; Szewczyk MM; Steuber H; Smil D; Wu H; Li F; Senisterra G; Dong A; Brown PJ; Hitchcock M; Moosmayer D; Stegmann CM; Egner U; Arrowsmith C; Barsyte-Lovejoy D; Vedadi M; Schapira M
    J Med Chem; 2016 Feb; 59(3):1176-83. PubMed ID: 26824386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule control of chromatin remodeling.
    Finley A; Copeland RA
    Chem Biol; 2014 Sep; 21(9):1196-210. PubMed ID: 25237863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current chemical biology approaches to interrogate protein methyltransferases.
    Luo M
    ACS Chem Biol; 2012 Mar; 7(3):443-63. PubMed ID: 22220966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule inhibitors of lysine methyltransferases SMYD2 and SMYD3: current trends.
    Fabini E; Manoni E; Ferroni C; Rio AD; Bartolini M
    Future Med Chem; 2019 Apr; 11(8):901-921. PubMed ID: 30998113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein methyltransferase inhibitors as precision cancer therapeutics: a decade of discovery.
    Copeland RA
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure, function and inhibition of the phosphoethanolamine methyltransferases of the human malaria parasites Plasmodium vivax and Plasmodium knowlesi.
    Garg A; Lukk T; Kumar V; Choi JY; Augagneur Y; Voelker DR; Nair S; Ben Mamoun C
    Sci Rep; 2015 Mar; 5():9064. PubMed ID: 25761669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting genetic alterations in protein methyltransferases for personalized cancer therapeutics.
    Copeland RA; Moyer MP; Richon VM
    Oncogene; 2013 Feb; 32(8):939-46. PubMed ID: 23160372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-guided DOT1L probe optimization by label-free ligand displacement.
    Yi JS; Federation AJ; Qi J; Dhe-Paganon S; Hadler M; Xu X; St Pierre R; Varca AC; Wu L; Marineau JJ; Smith WB; Souza A; Chory EJ; Armstrong SA; Bradner JE
    ACS Chem Biol; 2015 Mar; 10(3):667-74. PubMed ID: 25397901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical Inhibition of Protein Methyltransferases.
    Schapira M
    Cell Chem Biol; 2016 Sep; 23(9):1067-1076. PubMed ID: 27569753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathways: protein methyltransferases in cancer.
    Copeland RA
    Clin Cancer Res; 2013 Dec; 19(23):6344-50. PubMed ID: 23958745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Assays of Inhibitors of Methyltransferases.
    Cai XC; Kapilashrami K; Luo M
    Methods Enzymol; 2016; 574():245-308. PubMed ID: 27423865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysine acetyltransferase inhibitors: structure-activity relationships and potential therapeutic implications.
    Fiorentino F; Mai A; Rotili D
    Future Med Chem; 2018 May; 10(9):1067-1091. PubMed ID: 29676588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Situ Proteome Profiling and Bioimaging Applications of Small-Molecule Affinity-Based Probes Derived From DOT1L Inhibitors.
    Zhu B; Zhang H; Pan S; Wang C; Ge J; Lee JS; Yao SQ
    Chemistry; 2016 Jun; 22(23):7824-36. PubMed ID: 27115831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenoestrogens regulate the activity of arginine methyltransferases.
    Cheng D; Bedford MT
    Chembiochem; 2011 Jan; 12(2):323-9. PubMed ID: 21243720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.